Rank | Gene Set | Z-score |
---|---|---|
1 | cardiac myofibril assembly (GO:0055003) | 8.39882377 |
2 | sarcomere organization (GO:0045214) | 7.35769903 |
3 | myofibril assembly (GO:0030239) | 6.96158318 |
4 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.73747284 |
5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.70534247 |
6 | * regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.33447532 |
7 | * cardiac muscle contraction (GO:0060048) | 6.16722006 |
8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.07613217 |
9 | * cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.99124656 |
10 | * regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.79443794 |
11 | regulation of sarcomere organization (GO:0060297) | 5.74301655 |
12 | cardiac muscle hypertrophy (GO:0003300) | 5.74090848 |
13 | * regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.65419510 |
14 | actin-myosin filament sliding (GO:0033275) | 5.59836521 |
15 | muscle filament sliding (GO:0030049) | 5.59836521 |
16 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.45615050 |
17 | striated muscle hypertrophy (GO:0014897) | 5.41228236 |
18 | * cardiac muscle cell development (GO:0055013) | 5.34316604 |
19 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.29366340 |
20 | adult heart development (GO:0007512) | 5.29035404 |
21 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.26391037 |
22 | regulation of actin filament-based movement (GO:1903115) | 5.23899285 |
23 | * cell communication by electrical coupling (GO:0010644) | 5.22259156 |
24 | regulation of relaxation of muscle (GO:1901077) | 5.07790337 |
25 | actomyosin structure organization (GO:0031032) | 5.04440868 |
26 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.02870825 |
27 | * cardiac cell development (GO:0055006) | 4.98312318 |
28 | regulation of membrane repolarization (GO:0060306) | 4.95468840 |
29 | * cell communication involved in cardiac conduction (GO:0086065) | 4.95418503 |
30 | muscle hypertrophy (GO:0014896) | 4.81691497 |
31 | muscle tissue morphogenesis (GO:0060415) | 4.81567656 |
32 | actin-mediated cell contraction (GO:0070252) | 4.71207473 |
33 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.66906486 |
34 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.64412743 |
35 | tricarboxylic acid cycle (GO:0006099) | 4.63397669 |
36 | * striated muscle contraction (GO:0006941) | 4.51398811 |
37 | regulation of cell communication by electrical coupling (GO:0010649) | 4.48957648 |
38 | * regulation of the force of heart contraction (GO:0002026) | 4.38590854 |
39 | * regulation of striated muscle contraction (GO:0006942) | 4.35635661 |
40 | cardiac ventricle formation (GO:0003211) | 4.30221173 |
41 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 4.23524763 |
42 | heart trabecula formation (GO:0060347) | 4.20975786 |
43 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 4.19974520 |
44 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.19494680 |
45 | heart contraction (GO:0060047) | 4.16732475 |
46 | heart process (GO:0003015) | 4.16732475 |
47 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 4.16343099 |
48 | cardiac muscle cell action potential (GO:0086001) | 4.09232689 |
49 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.08308396 |
50 | muscle hypertrophy in response to stress (GO:0003299) | 4.08308396 |
51 | cardiac muscle adaptation (GO:0014887) | 4.08308396 |
52 | plasma membrane repair (GO:0001778) | 4.07217259 |
53 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.05951569 |
54 | cardiac conduction (GO:0061337) | 4.05125284 |
55 | regulation of cardioblast differentiation (GO:0051890) | 4.02093569 |
56 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.97815985 |
57 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.93722468 |
58 | * membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.93645012 |
59 | carnitine shuttle (GO:0006853) | 3.92585728 |
60 | negative regulation of potassium ion transport (GO:0043267) | 3.92510474 |
61 | atrial septum morphogenesis (GO:0060413) | 3.87463026 |
62 | detection of calcium ion (GO:0005513) | 3.83098945 |
63 | * regulation of cardiac muscle contraction (GO:0055117) | 3.82129168 |
64 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.78781211 |
65 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.78009121 |
66 | cellular potassium ion homeostasis (GO:0030007) | 3.77683548 |
67 | membrane repolarization during action potential (GO:0086011) | 3.77638483 |
68 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.77244163 |
69 | * regulation of heart rate (GO:0002027) | 3.75659743 |
70 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.73136761 |
71 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.69856575 |
72 | actin filament-based movement (GO:0030048) | 3.69249886 |
73 | regulation of skeletal muscle contraction (GO:0014819) | 3.63130043 |
74 | cardiac chamber formation (GO:0003207) | 3.61246508 |
75 | potassium ion export (GO:0071435) | 3.60379052 |
76 | * relaxation of cardiac muscle (GO:0055119) | 3.55355788 |
77 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.50842071 |
78 | adrenergic receptor signaling pathway (GO:0071875) | 3.50519218 |
79 | * negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.49954773 |
80 | * regulation of heart contraction (GO:0008016) | 3.49722732 |
81 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.49226991 |
82 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.46278582 |
83 | negative regulation of protein localization to cell surface (GO:2000009) | 3.43766949 |
84 | outflow tract septum morphogenesis (GO:0003148) | 3.36675768 |
85 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.36114259 |
86 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.36114259 |
87 | regulation of coenzyme metabolic process (GO:0051196) | 3.35940481 |
88 | regulation of cofactor metabolic process (GO:0051193) | 3.35940481 |
89 | fatty acid transmembrane transport (GO:1902001) | 3.34669563 |
90 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.33827783 |
91 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.31042744 |
92 | positive regulation of sodium ion transport (GO:0010765) | 3.29726137 |
93 | membrane repolarization (GO:0086009) | 3.28709953 |
94 | ventricular cardiac muscle cell development (GO:0055015) | 3.28073708 |
95 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.25925167 |
96 | cellular response to epinephrine stimulus (GO:0071872) | 3.25147613 |
97 | positive regulation of potassium ion transport (GO:0043268) | 3.24195215 |
98 | positive regulation of cation channel activity (GO:2001259) | 3.16514783 |
99 | response to epinephrine (GO:0071871) | 3.15329164 |
100 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.12851818 |
101 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.11086932 |
102 | * relaxation of muscle (GO:0090075) | 3.10310039 |
103 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.08528108 |
104 | regulation of ATP catabolic process (GO:1903289) | 3.06786869 |
105 | regulation of ATPase activity (GO:0043462) | 3.06786869 |
106 | positive regulation of muscle hypertrophy (GO:0014742) | 3.04424264 |
107 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.04424264 |
108 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.04285242 |
109 | * regulation of muscle contraction (GO:0006937) | 3.03929346 |
110 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.03658552 |
111 | * sodium ion export (GO:0071436) | 3.03188388 |
112 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.01901753 |
113 | positive regulation of ATP catabolic process (GO:1903291) | 3.01783735 |
114 | positive regulation of ATPase activity (GO:0032781) | 3.01783735 |
115 | positive regulation of heart contraction (GO:0045823) | 3.00832350 |
116 | regulation of cardiac muscle cell differentiation (GO:2000725) | 3.00209755 |
117 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.99435274 |
118 | positive regulation of heart rate (GO:0010460) | 2.98916932 |
119 | cardiac right ventricle morphogenesis (GO:0003215) | 2.97409657 |
120 | regulation of striated muscle cell apoptotic process (GO:0010662) | 2.96014373 |
121 | positive regulation of cardiac muscle tissue development (GO:0055025) | 2.92718719 |
122 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.92635708 |
123 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.92589149 |
124 | venous blood vessel morphogenesis (GO:0048845) | 2.91160731 |
125 | negative regulation of heart rate (GO:0010459) | 2.88730090 |
126 | * striated muscle cell development (GO:0055002) | 2.87947697 |
127 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.87095734 |
128 | presynaptic membrane assembly (GO:0097105) | 2.84576679 |
129 | potassium ion import (GO:0010107) | 2.83319095 |
130 | * membrane depolarization during action potential (GO:0086010) | 2.82190457 |
131 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.79623699 |
132 | startle response (GO:0001964) | 2.77895881 |
133 | positive regulation of heart growth (GO:0060421) | 2.77697877 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.81889915 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.54853967 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.80635649 |
4 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.56467987 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.42473847 |
6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.32003244 |
7 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.31911371 |
8 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.31911371 |
9 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.29737582 |
10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.15523764 |
11 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.07361548 |
12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.06515879 |
13 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99164788 |
14 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.99017222 |
15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.95276079 |
16 | VDR_22108803_ChIP-Seq_LS180_Human | 1.93636591 |
17 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.91455886 |
18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.89738787 |
19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.89738787 |
20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.88528220 |
21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.88064016 |
22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.83986786 |
23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.80608677 |
24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.77358816 |
25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.76879759 |
26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.69690764 |
27 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.68036792 |
28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.66922222 |
29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.66817301 |
30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.66325119 |
31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.64913874 |
32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62215269 |
33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61695556 |
34 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.60551600 |
35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58906876 |
36 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.57817815 |
37 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.55239075 |
38 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.54347180 |
39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.53366384 |
40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53028378 |
41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.49475338 |
42 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45362432 |
43 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.44586507 |
44 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.44342195 |
45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.44321959 |
46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43794116 |
47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43403707 |
48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41196636 |
49 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40355262 |
50 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.40355262 |
51 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.39867364 |
52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38430740 |
53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38140093 |
54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38140093 |
55 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.36754905 |
56 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.36496278 |
57 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34732463 |
58 | * AR_19668381_ChIP-Seq_PC3_Human | 1.33740957 |
59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33413955 |
60 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.33169632 |
61 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29235346 |
62 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26470201 |
63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25603583 |
64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24507351 |
65 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.24491963 |
66 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24121265 |
67 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.23783394 |
68 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.23160526 |
69 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23030471 |
70 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.23002144 |
71 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.22072924 |
72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21748081 |
73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21622491 |
74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21040991 |
75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20436572 |
76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.19911196 |
77 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.19199720 |
78 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19172901 |
79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18265110 |
80 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17356414 |
81 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16988477 |
82 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16798018 |
83 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.16194943 |
84 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15708970 |
85 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14258580 |
86 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13298098 |
87 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12909239 |
88 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11723780 |
89 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11493664 |
90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11128007 |
91 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10145263 |
92 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.10018020 |
93 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.09784230 |
94 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.09585132 |
95 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09321570 |
96 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08928949 |
97 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.08270074 |
98 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07865055 |
99 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07781092 |
100 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.07159339 |
101 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06569162 |
102 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06367244 |
103 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.05685239 |
104 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05159494 |
105 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05133411 |
106 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04884027 |
107 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04351530 |
108 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04055190 |
109 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.03879672 |
110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03714170 |
111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03696248 |
112 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03599620 |
113 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03187307 |
114 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01479400 |
115 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97933184 |
116 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.97453238 |
117 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97291344 |
118 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95763449 |
119 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95741912 |
120 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95696369 |
121 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93979700 |
122 | AR_25329375_ChIP-Seq_VCAP_Human | 0.92229550 |
123 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.91725149 |
124 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90569248 |
125 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90488558 |
126 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89593357 |
127 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88815928 |
128 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.88414498 |
129 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.88178859 |
130 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87497912 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0004084_abnormal_cardiac_muscle | 6.08066747 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 5.96753155 |
3 | MP0004215_abnormal_myocardial_fiber | 5.04735745 |
4 | * MP0004036_abnormal_muscle_relaxation | 4.14403357 |
5 | MP0000751_myopathy | 4.06699570 |
6 | MP0005330_cardiomyopathy | 3.88128776 |
7 | MP0003646_muscle_fatigue | 3.45269690 |
8 | * MP0008775_abnormal_heart_ventricle | 3.36927967 |
9 | * MP0002972_abnormal_cardiac_muscle | 3.33070558 |
10 | MP0000749_muscle_degeneration | 3.27711674 |
11 | MP0003137_abnormal_impulse_conducting | 3.18280128 |
12 | MP0004510_myositis | 2.92998257 |
13 | * MP0005620_abnormal_muscle_contractility | 2.78626990 |
14 | * MP0004087_abnormal_muscle_fiber | 2.72517491 |
15 | * MP0010630_abnormal_cardiac_muscle | 2.57322490 |
16 | * MP0004085_abnormal_heartbeat | 2.53702458 |
17 | * MP0005385_cardiovascular_system_phenoty | 2.48346725 |
18 | * MP0001544_abnormal_cardiovascular_syste | 2.48346725 |
19 | MP0004145_abnormal_muscle_electrophysio | 2.44018217 |
20 | MP0004484_altered_response_of | 2.41213538 |
21 | MP0006138_congestive_heart_failure | 2.39879372 |
22 | MP0000569_abnormal_digit_pigmentation | 2.37178392 |
23 | MP0003828_pulmonary_edema | 2.33693924 |
24 | MP0004233_abnormal_muscle_weight | 2.32204529 |
25 | MP0005423_abnormal_somatic_nervous | 2.18418230 |
26 | MP0002106_abnormal_muscle_physiology | 2.14056858 |
27 | MP0004130_abnormal_muscle_cell | 2.09033663 |
28 | MP0002127_abnormal_cardiovascular_syste | 1.88952495 |
29 | MP0002269_muscular_atrophy | 1.88286819 |
30 | MP0000750_abnormal_muscle_regeneration | 1.81198796 |
31 | MP0005369_muscle_phenotype | 1.71088725 |
32 | * MP0003221_abnormal_cardiomyocyte_apopto | 1.67704542 |
33 | MP0002102_abnormal_ear_morphology | 1.66896826 |
34 | MP0003950_abnormal_plasma_membrane | 1.62401871 |
35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.53398276 |
36 | MP0004859_abnormal_synaptic_plasticity | 1.53277727 |
37 | MP0002822_catalepsy | 1.49802555 |
38 | MP0000759_abnormal_skeletal_muscle | 1.41644493 |
39 | MP0000747_muscle_weakness | 1.41344660 |
40 | MP0001501_abnormal_sleep_pattern | 1.36384266 |
41 | MP0002332_abnormal_exercise_endurance | 1.34721390 |
42 | MP0002090_abnormal_vision | 1.27029855 |
43 | MP0002234_abnormal_pharynx_morphology | 1.26846032 |
44 | MP0010386_abnormal_urinary_bladder | 1.22741431 |
45 | MP0003122_maternal_imprinting | 1.21421655 |
46 | MP0002909_abnormal_adrenal_gland | 1.17826730 |
47 | MP0003045_fibrosis | 1.17354620 |
48 | * MP0000266_abnormal_heart_morphology | 1.17310651 |
49 | MP0010368_abnormal_lymphatic_system | 1.17047523 |
50 | MP0001970_abnormal_pain_threshold | 1.16468387 |
51 | MP0006276_abnormal_autonomic_nervous | 1.15347858 |
52 | MP0000778_abnormal_nervous_system | 1.11150987 |
53 | MP0005551_abnormal_eye_electrophysiolog | 1.10426735 |
54 | MP0001440_abnormal_grooming_behavior | 1.09703000 |
55 | MP0001968_abnormal_touch/_nociception | 1.08154396 |
56 | MP0003879_abnormal_hair_cell | 1.07549108 |
57 | MP0000462_abnormal_digestive_system | 1.00881686 |
58 | MP0005623_abnormal_meninges_morphology | 1.00204039 |
59 | MP0000230_abnormal_systemic_arterial | 0.97691333 |
60 | MP0005451_abnormal_body_composition | 0.96287564 |
61 | MP0003635_abnormal_synaptic_transmissio | 0.95983038 |
62 | MP0009780_abnormal_chondrocyte_physiolo | 0.95235935 |
63 | MP0006072_abnormal_retinal_apoptosis | 0.94958998 |
64 | MP0002638_abnormal_pupillary_reflex | 0.94675065 |
65 | MP0003279_aneurysm | 0.93237822 |
66 | MP0008874_decreased_physiological_sensi | 0.90013927 |
67 | MP0006036_abnormal_mitochondrial_physio | 0.88627727 |
68 | MP0001299_abnormal_eye_distance/ | 0.83076431 |
69 | MP0002882_abnormal_neuron_morphology | 0.81204244 |
70 | MP0002733_abnormal_thermal_nociception | 0.80878060 |
71 | MP0005165_increased_susceptibility_to | 0.80180579 |
72 | MP0005670_abnormal_white_adipose | 0.80045802 |
73 | MP0002066_abnormal_motor_capabilities/c | 0.79000557 |
74 | MP0004272_abnormal_basement_membrane | 0.77776348 |
75 | MP0004142_abnormal_muscle_tone | 0.77025104 |
76 | MP0003690_abnormal_glial_cell | 0.76737588 |
77 | MP0002184_abnormal_innervation | 0.75624038 |
78 | MP0002063_abnormal_learning/memory/cond | 0.75586636 |
79 | MP0004811_abnormal_neuron_physiology | 0.75365523 |
80 | MP0000013_abnormal_adipose_tissue | 0.74410446 |
81 | MP0005595_abnormal_vascular_smooth | 0.74401141 |
82 | MP0005248_abnormal_Harderian_gland | 0.74221375 |
83 | MP0009046_muscle_twitch | 0.73526490 |
84 | MP0003787_abnormal_imprinting | 0.73406870 |
85 | MP0003566_abnormal_cell_adhesion | 0.72165730 |
86 | MP0005503_abnormal_tendon_morphology | 0.71799495 |
87 | MP0002557_abnormal_social/conspecific_i | 0.71682686 |
88 | MP0004742_abnormal_vestibular_system | 0.71099804 |
89 | MP0004924_abnormal_behavior | 0.70939280 |
90 | MP0005386_behavior/neurological_phenoty | 0.70939280 |
91 | MP0005666_abnormal_adipose_tissue | 0.70302160 |
92 | MP0003329_amyloid_beta_deposits | 0.69660082 |
93 | MP0003631_nervous_system_phenotype | 0.69505191 |
94 | MP0002064_seizures | 0.68464378 |
95 | * MP0002128_abnormal_blood_circulation | 0.68369906 |
96 | MP0000955_abnormal_spinal_cord | 0.67821259 |
97 | MP0009745_abnormal_behavioral_response | 0.67065606 |
98 | MP0009384_cardiac_valve_regurgitation | 0.63734202 |
99 | MP0004858_abnormal_nervous_system | 0.63475649 |
100 | MP0001529_abnormal_vocalization | 0.62014220 |
101 | MP0002108_abnormal_muscle_morphology | 0.59545003 |
102 | MP0003880_abnormal_central_pattern | 0.59196676 |
103 | MP0003890_abnormal_embryonic-extraembry | 0.58740927 |
104 | MP0000343_altered_response_to | 0.58341384 |
105 | MP0001986_abnormal_taste_sensitivity | 0.57278515 |
106 | MP0003121_genomic_imprinting | 0.55594794 |
107 | MP0008961_abnormal_basal_metabolism | 0.54545227 |
108 | MP0002229_neurodegeneration | 0.54446363 |
109 | MP0002272_abnormal_nervous_system | 0.54416188 |
110 | * MP0002925_abnormal_cardiovascular_devel | 0.54151551 |
111 | MP0001984_abnormal_olfaction | 0.53797693 |
112 | MP0004270_analgesia | 0.53717322 |
113 | MP0002067_abnormal_sensory_capabilities | 0.53205693 |
114 | MP0000920_abnormal_myelination | 0.53017991 |
115 | MP0001963_abnormal_hearing_physiology | 0.52459978 |
116 | MP0001879_abnormal_lymphatic_vessel | 0.52358800 |
117 | MP0001486_abnormal_startle_reflex | 0.50932884 |
118 | MP0001502_abnormal_circadian_rhythm | 0.50429721 |
119 | MP0005375_adipose_tissue_phenotype | 0.49925163 |
120 | MP0002734_abnormal_mechanical_nocicepti | 0.49806555 |
121 | MP0005253_abnormal_eye_physiology | 0.49415844 |
122 | * MP0006035_abnormal_mitochondrial_morpho | 0.48836471 |
123 | MP0008569_lethality_at_weaning | 0.48632777 |
124 | MP0005266_abnormal_metabolism | 0.48530214 |
125 | MP0000767_abnormal_smooth_muscle | 0.47428398 |
126 | MP0005187_abnormal_penis_morphology | 0.47341348 |
127 | MP0003633_abnormal_nervous_system | 0.45919138 |
128 | MP0002735_abnormal_chemical_nociception | 0.44133309 |
129 | MP0003172_abnormal_lysosome_physiology | 0.43332446 |
130 | MP0002078_abnormal_glucose_homeostasis | 0.42913677 |
131 | MP0000003_abnormal_adipose_tissue | 0.42396240 |
132 | MP0004043_abnormal_pH_regulation | 0.41882112 |
133 | MP0003948_abnormal_gas_homeostasis | 0.41269273 |
134 | * MP0001784_abnormal_fluid_regulation | 0.40389462 |
135 | MP0003705_abnormal_hypodermis_morpholog | 0.38620426 |
136 | MP0002572_abnormal_emotion/affect_behav | 0.38103920 |
137 | MP0005535_abnormal_body_temperature | 0.37616678 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 9.08178642 |
2 | Atrial fibrillation (HP:0005110) | 6.80099118 |
3 | Ventricular tachycardia (HP:0004756) | 6.39796981 |
4 | Primary atrial arrhythmia (HP:0001692) | 6.38659976 |
5 | Supraventricular tachycardia (HP:0004755) | 6.12113909 |
6 | Supraventricular arrhythmia (HP:0005115) | 6.00429313 |
7 | Syncope (HP:0001279) | 5.96949784 |
8 | Exercise-induced muscle cramps (HP:0003710) | 5.61128902 |
9 | Prolonged QT interval (HP:0001657) | 5.46107061 |
10 | Subaortic stenosis (HP:0001682) | 5.44866414 |
11 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.44866414 |
12 | Lipoatrophy (HP:0100578) | 5.26527017 |
13 | Calf muscle hypertrophy (HP:0008981) | 5.24888424 |
14 | Abnormality of the calf musculature (HP:0001430) | 5.02639949 |
15 | Ventricular arrhythmia (HP:0004308) | 4.87908054 |
16 | Exercise-induced myalgia (HP:0003738) | 4.86687545 |
17 | Ventricular fibrillation (HP:0001663) | 4.80181842 |
18 | Right ventricular cardiomyopathy (HP:0011663) | 4.76316693 |
19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.61395702 |
20 | Focal motor seizures (HP:0011153) | 4.59075604 |
21 | Atonic seizures (HP:0010819) | 4.47472604 |
22 | Febrile seizures (HP:0002373) | 4.39151276 |
23 | Palpitations (HP:0001962) | 4.35775937 |
24 | Dilated cardiomyopathy (HP:0001644) | 4.28890370 |
25 | Myoglobinuria (HP:0002913) | 4.18594177 |
26 | Muscle fiber splitting (HP:0003555) | 4.11944493 |
27 | Abnormal EKG (HP:0003115) | 4.09445026 |
28 | Asymmetric septal hypertrophy (HP:0001670) | 4.07404937 |
29 | Bundle branch block (HP:0011710) | 4.02583828 |
30 | Hyporeflexia of lower limbs (HP:0002600) | 3.96034258 |
31 | EMG: myopathic abnormalities (HP:0003458) | 3.78731246 |
32 | Hip contracture (HP:0003273) | 3.72039401 |
33 | Heart block (HP:0012722) | 3.38824936 |
34 | Atrioventricular block (HP:0001678) | 3.38688835 |
35 | Focal seizures (HP:0007359) | 3.37666535 |
36 | Left ventricular hypertrophy (HP:0001712) | 3.36132089 |
37 | Myokymia (HP:0002411) | 3.32824233 |
38 | Broad-based gait (HP:0002136) | 3.31716686 |
39 | Hyperventilation (HP:0002883) | 3.30879062 |
40 | Action tremor (HP:0002345) | 3.28542105 |
41 | Abnormal atrioventricular conduction (HP:0005150) | 3.13032729 |
42 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.98437438 |
43 | Progressive cerebellar ataxia (HP:0002073) | 2.88562977 |
44 | Limited hip movement (HP:0008800) | 2.88023900 |
45 | Rhabdomyolysis (HP:0003201) | 2.81705342 |
46 | Pheochromocytoma (HP:0002666) | 2.78846141 |
47 | Central scotoma (HP:0000603) | 2.77431055 |
48 | Dialeptic seizures (HP:0011146) | 2.77398151 |
49 | Ragged-red muscle fibers (HP:0003200) | 2.75912807 |
50 | Gaze-evoked nystagmus (HP:0000640) | 2.75671249 |
51 | Absence seizures (HP:0002121) | 2.73670509 |
52 | Aplasia of the musculature (HP:0100854) | 2.60897138 |
53 | Congenital stationary night blindness (HP:0007642) | 2.57640307 |
54 | Drooling (HP:0002307) | 2.56480833 |
55 | Sudden cardiac death (HP:0001645) | 2.48368346 |
56 | Congenital malformation of the right heart (HP:0011723) | 2.48187793 |
57 | Double outlet right ventricle (HP:0001719) | 2.48187793 |
58 | Neuroendocrine neoplasm (HP:0100634) | 2.46917825 |
59 | Fetal akinesia sequence (HP:0001989) | 2.46592544 |
60 | Myotonia (HP:0002486) | 2.44271701 |
61 | Palmoplantar keratoderma (HP:0000982) | 2.42992990 |
62 | Excessive salivation (HP:0003781) | 2.38938163 |
63 | Truncal ataxia (HP:0002078) | 2.34981946 |
64 | Generalized tonic-clonic seizures (HP:0002069) | 2.33209787 |
65 | Increased connective tissue (HP:0009025) | 2.30840127 |
66 | Difficulty running (HP:0009046) | 2.24647229 |
67 | Neoplasm of the adrenal gland (HP:0100631) | 2.23266888 |
68 | Hip dysplasia (HP:0001385) | 2.22847034 |
69 | Dysdiadochokinesis (HP:0002075) | 2.22086053 |
70 | Ketoacidosis (HP:0001993) | 2.21766057 |
71 | Lymphangioma (HP:0100764) | 2.20489400 |
72 | Papillary thyroid carcinoma (HP:0002895) | 2.20386128 |
73 | EMG: neuropathic changes (HP:0003445) | 2.18373729 |
74 | Diaphragmatic weakness (HP:0009113) | 2.17953875 |
75 | Hamartoma of the eye (HP:0010568) | 2.17113163 |
76 | Congestive heart failure (HP:0001635) | 2.15716146 |
77 | Type 1 muscle fiber predominance (HP:0003803) | 2.12694055 |
78 | Abnormality of the foot musculature (HP:0001436) | 2.08092066 |
79 | Patent foramen ovale (HP:0001655) | 2.07576907 |
80 | Dysmetric saccades (HP:0000641) | 2.06852356 |
81 | Conjunctival hamartoma (HP:0100780) | 2.05093376 |
82 | Scanning speech (HP:0002168) | 2.03262051 |
83 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.01368056 |
84 | Rimmed vacuoles (HP:0003805) | 2.00430706 |
85 | Hypoglycemic coma (HP:0001325) | 1.97121308 |
86 | Neck muscle weakness (HP:0000467) | 1.96660146 |
87 | Urinary urgency (HP:0000012) | 1.96532170 |
88 | Postural instability (HP:0002172) | 1.93581135 |
89 | Scapular winging (HP:0003691) | 1.93011203 |
90 | Obstructive sleep apnea (HP:0002870) | 1.90989547 |
91 | Protruding tongue (HP:0010808) | 1.88775951 |
92 | Gowers sign (HP:0003391) | 1.88220992 |
93 | Knee flexion contracture (HP:0006380) | 1.87007418 |
94 | Generalized muscle weakness (HP:0003324) | 1.85284552 |
95 | Inability to walk (HP:0002540) | 1.84361079 |
96 | Steppage gait (HP:0003376) | 1.80779300 |
97 | Difficulty climbing stairs (HP:0003551) | 1.78986843 |
98 | Scotoma (HP:0000575) | 1.77681248 |
99 | Abnormality of the tricuspid valve (HP:0001702) | 1.77228921 |
100 | Lower limb muscle weakness (HP:0007340) | 1.77127058 |
101 | Bradycardia (HP:0001662) | 1.76799687 |
102 | Complete atrioventricular canal defect (HP:0001674) | 1.76727286 |
103 | Spinal muscular atrophy (HP:0007269) | 1.76116035 |
104 | Hypoplastic left heart (HP:0004383) | 1.75669865 |
105 | Epileptiform EEG discharges (HP:0011182) | 1.74859907 |
106 | Toxemia of pregnancy (HP:0100603) | 1.73619813 |
107 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.73025118 |
108 | Broad metatarsal (HP:0001783) | 1.72050144 |
109 | Decreased circulating renin level (HP:0003351) | 1.70569404 |
110 | Foot dorsiflexor weakness (HP:0009027) | 1.68515079 |
111 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.67800142 |
112 | Increased variability in muscle fiber diameter (HP:0003557) | 1.66731679 |
113 | Abnormality of the endocardium (HP:0004306) | 1.66116157 |
114 | Large for gestational age (HP:0001520) | 1.65698844 |
115 | Progressive inability to walk (HP:0002505) | 1.64633924 |
116 | Muscle stiffness (HP:0003552) | 1.64185874 |
117 | Papilledema (HP:0001085) | 1.63975223 |
118 | Hypoplastic ischia (HP:0003175) | 1.63861309 |
119 | Absent speech (HP:0001344) | 1.62849667 |
120 | Hepatic necrosis (HP:0002605) | 1.62152438 |
121 | Dysmetria (HP:0001310) | 1.60744285 |
122 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.59017967 |
123 | Abnormality of salivation (HP:0100755) | 1.57739665 |
124 | Tinnitus (HP:0000360) | 1.56833671 |
125 | Hemiplegia (HP:0002301) | 1.55814471 |
126 | Hemiparesis (HP:0001269) | 1.55800790 |
127 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.54596231 |
128 | Atrioventricular canal defect (HP:0006695) | 1.54351874 |
129 | Vitreoretinal degeneration (HP:0000655) | 1.53673811 |
130 | Limb-girdle muscle atrophy (HP:0003797) | 1.52176770 |
131 | Pulmonary artery stenosis (HP:0004415) | 1.52037109 |
132 | Bicuspid aortic valve (HP:0001647) | 1.51877076 |
133 | Genetic anticipation (HP:0003743) | 1.51404463 |
134 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.51311972 |
135 | Lower limb amyotrophy (HP:0007210) | 1.50902253 |
136 | Distal lower limb muscle weakness (HP:0009053) | 1.50673783 |
137 | Muscular dystrophy (HP:0003560) | 1.50581170 |
138 | Poor eye contact (HP:0000817) | 1.50324536 |
139 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.50060957 |
140 | Athetosis (HP:0002305) | 1.49225626 |
141 | Aneurysm (HP:0002617) | 1.48866589 |
142 | Hyperglycemia (HP:0003074) | 1.47757245 |
143 | Subacute progressive viral hepatitis (HP:0006572) | 1.47283711 |
144 | Cerebral aneurysm (HP:0004944) | 1.47131229 |
145 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.47058219 |
146 | Childhood onset (HP:0011463) | 1.47015368 |
147 | Preauricular pit (HP:0004467) | 1.46986085 |
148 | Periauricular skin pits (HP:0100277) | 1.46986085 |
149 | Acute necrotizing encephalopathy (HP:0006965) | 1.46693273 |
150 | Epileptic encephalopathy (HP:0200134) | 1.46420014 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 5.29520536 |
2 | PKN2 | 3.84654016 |
3 | MYLK | 3.56728622 |
4 | PHKG2 | 3.49587880 |
5 | PHKG1 | 3.49587880 |
6 | CASK | 3.32548158 |
7 | DMPK | 3.23756349 |
8 | LMTK2 | 3.11501022 |
9 | TTN | 2.92449289 |
10 | STK24 | 2.65089749 |
11 | NEK1 | 2.64384567 |
12 | FRK | 2.56809538 |
13 | PDK4 | 2.23470766 |
14 | PDK3 | 2.23470766 |
15 | PIK3CA | 1.94675250 |
16 | INSRR | 1.82491270 |
17 | TRIB3 | 1.82331556 |
18 | MARK1 | 1.76473712 |
19 | CDC42BPA | 1.75138069 |
20 | RIPK1 | 1.71299003 |
21 | AKT3 | 1.70680253 |
22 | TIE1 | 1.60139246 |
23 | PAK3 | 1.59321434 |
24 | CAMK2D | 1.39432615 |
25 | ILK | 1.37729628 |
26 | MAP3K7 | 1.36631944 |
27 | TNIK | 1.34275575 |
28 | ZAK | 1.27579747 |
29 | EPHA3 | 1.26782808 |
30 | ROCK1 | 1.26621870 |
31 | GRK7 | 1.24681129 |
32 | MAP2K7 | 1.19273880 |
33 | STK38 | 1.13821369 |
34 | PDK2 | 1.12617003 |
35 | PRKD1 | 1.11680995 |
36 | CAMK2B | 1.10680183 |
37 | PINK1 | 1.08398620 |
38 | DAPK3 | 1.07673747 |
39 | MAP3K12 | 1.05220153 |
40 | WNK4 | 1.04318145 |
41 | PRKAA1 | 1.01343313 |
42 | MINK1 | 0.99919431 |
43 | PAK6 | 0.98894396 |
44 | CAMK1 | 0.97114029 |
45 | MAP3K4 | 0.95040158 |
46 | STK38L | 0.92224210 |
47 | EPHA4 | 0.91091471 |
48 | PTK2B | 0.88721436 |
49 | FLT3 | 0.88659840 |
50 | CAMK2A | 0.88168875 |
51 | CCNB1 | 0.86520025 |
52 | PKN1 | 0.84518347 |
53 | MAPK12 | 0.83439785 |
54 | WNK3 | 0.83378421 |
55 | CAMK4 | 0.81789879 |
56 | MUSK | 0.80262814 |
57 | PRKD3 | 0.78715945 |
58 | MAP3K9 | 0.78713596 |
59 | CAMKK1 | 0.78450490 |
60 | WNK1 | 0.77188249 |
61 | PDGFRA | 0.73293449 |
62 | FER | 0.72323791 |
63 | MAPK7 | 0.71170225 |
64 | PRKAA2 | 0.70376734 |
65 | LATS1 | 0.69540874 |
66 | NTRK3 | 0.68166821 |
67 | MAP3K6 | 0.67928307 |
68 | MAP3K5 | 0.66628429 |
69 | PRKCG | 0.66320599 |
70 | NEK9 | 0.66105609 |
71 | PRKCE | 0.63009835 |
72 | TRPM7 | 0.62578186 |
73 | KSR1 | 0.61921908 |
74 | CSNK1G2 | 0.60375151 |
75 | ADRBK1 | 0.60306614 |
76 | OXSR1 | 0.59556436 |
77 | ROCK2 | 0.59486293 |
78 | PRKACB | 0.59196399 |
79 | RET | 0.58181130 |
80 | PRPF4B | 0.57950116 |
81 | CAMK1D | 0.54516015 |
82 | NTRK1 | 0.54333418 |
83 | ADRBK2 | 0.53546576 |
84 | TGFBR2 | 0.53363143 |
85 | DAPK2 | 0.52378639 |
86 | UHMK1 | 0.52086793 |
87 | BLK | 0.51844283 |
88 | ERBB3 | 0.51762735 |
89 | MAP3K10 | 0.51626390 |
90 | GRK5 | 0.49585982 |
91 | PDK1 | 0.48356302 |
92 | LIMK1 | 0.47926445 |
93 | CAMK2G | 0.47833386 |
94 | STK39 | 0.47636282 |
95 | ACVR1B | 0.47623435 |
96 | CSNK1A1L | 0.46785684 |
97 | PRKACG | 0.46675599 |
98 | CAMK1G | 0.46504678 |
99 | ICK | 0.46495710 |
100 | PRKG1 | 0.46418654 |
101 | MARK2 | 0.45868860 |
102 | NTRK2 | 0.45666051 |
103 | CDK5 | 0.45544418 |
104 | PRKACA | 0.45360802 |
105 | KSR2 | 0.45175112 |
106 | SGK223 | 0.40401927 |
107 | SGK494 | 0.40401927 |
108 | SGK3 | 0.40319079 |
109 | RAF1 | 0.39734730 |
110 | SGK1 | 0.39687941 |
111 | PRKCH | 0.39659048 |
112 | PDPK1 | 0.38769009 |
113 | RPS6KA2 | 0.38631413 |
114 | STK4 | 0.37839298 |
115 | RPS6KA3 | 0.37160548 |
116 | LATS2 | 0.37014673 |
117 | MAP2K4 | 0.36969651 |
118 | PTK6 | 0.36587150 |
119 | SGK2 | 0.36562647 |
120 | STK11 | 0.35234638 |
121 | BCR | 0.34612748 |
122 | BCKDK | 0.34582876 |
123 | MAPK10 | 0.33989356 |
124 | PRKCZ | 0.32624110 |
125 | FYN | 0.32210615 |
126 | RPS6KL1 | 0.31888938 |
127 | RPS6KC1 | 0.31888938 |
128 | DYRK1A | 0.31752458 |
129 | FGFR1 | 0.30186838 |
130 | MAPK13 | 0.29638315 |
131 | CAMKK2 | 0.29274997 |
132 | PLK2 | 0.27822477 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.36045607 |
2 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.89798740 |
3 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.80446272 |
4 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.58899581 |
5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.02234188 |
6 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.40308130 |
7 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.38021529 |
8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.31559154 |
9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.84396748 |
10 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.67827366 |
11 | Carbon metabolism_Homo sapiens_hsa01200 | 1.64833032 |
12 | Parkinsons disease_Homo sapiens_hsa05012 | 1.52576801 |
13 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50327965 |
14 | Insulin secretion_Homo sapiens_hsa04911 | 1.50255149 |
15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.49240956 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.47872385 |
17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.47850690 |
18 | Renin secretion_Homo sapiens_hsa04924 | 1.46843387 |
19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.45164592 |
20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.39769714 |
21 | Morphine addiction_Homo sapiens_hsa05032 | 1.38590824 |
22 | Nicotine addiction_Homo sapiens_hsa05033 | 1.38575799 |
23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.36285332 |
24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.35037158 |
25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.30603925 |
26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.29395914 |
27 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.23313920 |
28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21641512 |
29 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.21140599 |
30 | Salivary secretion_Homo sapiens_hsa04970 | 1.18504247 |
31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17882754 |
32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14137642 |
33 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.14027237 |
34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.10351626 |
35 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05283377 |
36 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.05204839 |
37 | Circadian rhythm_Homo sapiens_hsa04710 | 1.03791667 |
38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03586352 |
39 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.02902062 |
40 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.02243079 |
41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.00912744 |
42 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.98353222 |
43 | Long-term potentiation_Homo sapiens_hsa04720 | 0.95495619 |
44 | Insulin resistance_Homo sapiens_hsa04931 | 0.95361156 |
45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94815454 |
46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94149766 |
47 | * Olfactory transduction_Homo sapiens_hsa04740 | 0.93029138 |
48 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.92752819 |
49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92154607 |
50 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.89303907 |
51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.88706090 |
52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.88700796 |
53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.88567689 |
54 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.87771518 |
55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.85082650 |
56 | Huntingtons disease_Homo sapiens_hsa05016 | 0.84141857 |
57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83813135 |
58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82873464 |
59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.82321531 |
60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78855147 |
61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.78799359 |
62 | Gap junction_Homo sapiens_hsa04540 | 0.78793089 |
63 | Focal adhesion_Homo sapiens_hsa04510 | 0.78584438 |
64 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.78289698 |
65 | Taste transduction_Homo sapiens_hsa04742 | 0.76022585 |
66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75256379 |
67 | Bile secretion_Homo sapiens_hsa04976 | 0.72121039 |
68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71160541 |
69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71124833 |
70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70826644 |
71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67257599 |
72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65695952 |
73 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64334357 |
74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64317256 |
75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64018559 |
76 | Tight junction_Homo sapiens_hsa04530 | 0.63431203 |
77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62902259 |
78 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61052253 |
79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.60354850 |
80 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58296998 |
81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58167090 |
82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56776983 |
83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55171851 |
84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54334409 |
85 | * Mineral absorption_Homo sapiens_hsa04978 | 0.53667790 |
86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52409197 |
87 | Phototransduction_Homo sapiens_hsa04744 | 0.51893920 |
88 | Lysine degradation_Homo sapiens_hsa00310 | 0.51678370 |
89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49897939 |
90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49586764 |
91 | Adherens junction_Homo sapiens_hsa04520 | 0.48837437 |
92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48247691 |
93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47495366 |
94 | Long-term depression_Homo sapiens_hsa04730 | 0.45958954 |
95 | Axon guidance_Homo sapiens_hsa04360 | 0.45521610 |
96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43404036 |
97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43215606 |
98 | Amoebiasis_Homo sapiens_hsa05146 | 0.41876464 |
99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41651019 |
100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41147224 |
101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40964664 |
102 | Platelet activation_Homo sapiens_hsa04611 | 0.40320108 |
103 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39972291 |
104 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.39636898 |
105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39024991 |
106 | Glioma_Homo sapiens_hsa05214 | 0.38769954 |
107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37971601 |
108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35944090 |
109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35796432 |
110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35516845 |
111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.34182793 |
112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33996761 |
113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33648750 |
114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33106341 |
115 | Melanogenesis_Homo sapiens_hsa04916 | 0.32839723 |
116 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.32752295 |
117 | Cocaine addiction_Homo sapiens_hsa05030 | 0.32001951 |
118 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31571497 |
119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29816189 |
120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28991743 |
121 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28892676 |
122 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.28514267 |
123 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28077668 |
124 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26709178 |
125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26429122 |
126 | ABC transporters_Homo sapiens_hsa02010 | 0.21625901 |